Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy

Magnetic Resonance Imaging

Volumn 29, Issue 1, 2011, Pages 25-31

  Zeng, QingShi ^a   Liu, HePeng ^a   Zhang, Kai ^a   Li, ChuanFu ^a   Zhou, GengYin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Brain; Glioma; Magnetic resonance (MR); Proton MR spectroscopy; Tumor grade

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ASPARTIC ACID; BRAIN NEOPLASMS; CHOLINE; CREATINE; FEMALE; GLIOMA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

NUCLEOPOLYHEDROVIRUS;

EID: 78649959463     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.07.017     Document Type: Article

References (23)

1. Dean B.L., Drayer B.P., Bird C.R., Flom R.A., Hodak J.A., Coons S.W., et al. Gliomas: classification with MR imaging. Radiology 1990, 174:411-415.
2. Möller-Hartmann W., Herminghaus S., Krings T., Marquardt G., Lanfermann H., Pilatus U., et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002, 44:371-381.
3. Law M., Yang S., Wang H., Babb J.S., Johnson G., Cha S., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003, 24:1989-1998.
4. Al-Okaili R.N., Krejza J., Woo J.H., Wolf R.L., O'Rourke D.M., Judy K.D., et al. Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 2007, 243:539-550.
5. Watanabe M., Tanaka R., Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992, 34:463-469.
6. Kondziolka D., Lunsford L.D., Martinez A.J. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993, 79:533-536.
7. Knopp E.A., Cha S., Johnson G., Mazumdar A., Golfinos J.G., Zagzag D., et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999, 211:791-798.
8. 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiol 2006, 27:1412-1418.
9. McKnight T.R., von dem Bussche M.H., Vigneron D.B., Lu Y., Berger M.S., McDermott M.W., et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002, 97:794-802.
10. Pirzkall A., Li X., Oh J., Chang S., Berger M.S., Larson D.A., et al. Nelson SJ 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004, 59:126-137.
11. 1H-MR spectroscopy. Diagn Interv Radiol 2007, 13:3-9.
12. Stadlbauer A., Gruber S., Nimsky C., Fahlbusch R., Hammen T., Buslei R., et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006, 238:958-969.
13. Li B.S., Babb J.S., Soher B.J., Maudsley A.A., Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002, 47:439-446.
14. Bulakbasi N., Kocaoglu M., Ors F., Tayfun C., Uçöz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003, 24:225-233.
15. Murakami R., Hirai T., Sugahara T., Fukuoka H., Toya R., Nishimura S., et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 2009, 251:838-845.
16. Zonari P., Baraldi P., Crisi G. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007, 49:795-803.
17. Soares D.P., Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009, 64:12-21.
18. 1H MRS of the human brain at high magnetic fields. Magn Reson Med 2001, 46:1049-1053.
19. Toyooka M., Kimura H., Uematsu H., Kawamura Y., Takeuchi H., Itoh H. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Clin Imaging 2008, 32:251-258.
20. Shimizu H., Kumabe T., Shirane R., Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000, 21:659-665.
21. Kelley D.A.C., Wald L.L., Star-Lack J.M. Lactate detection at 3T: compensating J coupling effects with BASING. J Magn Reson Imaging 1999, 9:732-737.
22. Hancu I. Which pulse sequence is optimal for myo-inositol detection at 3T?. NMR Biomed 2009, 22:426-435.
23. Wrensch M., Minn Y., Chew T., Bondy M., Berger M.S. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002, 4:278-299.